Automated Cerebrospinal Fluid Cell Counter Granted USA Diagnostics Marketing Approval
By LabMedica International staff writers Posted on 18 Jul 2016 |
Image: The GloCyte system delivers highly accurate and precise total nucleated cell (TNC) and red blood cell (RBC) counts in samples of cerebrospinal fluid (CSF) (Photo courtesy of Advanced Instruments).
The [U.S.] Food and Drug Administration has granted diagnostic use marketing approval (510(k) clearance) for an automated cell counting system that accurately quantifies the low number of cells found in cerebrospinal fluid (CSF).
The Advanced Instruments, Inc., (Norwood, MA, USA) patented GloCyte Automated Cell Counter System delivers highly accurate and precise total nucleated cell (TNC) and red blood cell (RBC) results using a novel combination of fluorescence technology, highly specific reagents, and an intelligent counting algorithm. It provides accurate cell counts at clinically relevant low levels and reduces valuable time spent counting those more difficult specimens.
Analyses preformed with the GloCyteSystem require only 30 microliters of sample per test. The instrument uses disposable test cartridges ensuring no sample carryover and easy disposal, and it includes built-in quality control.
The GloCyte instrument, which should be available in the USA from September 2016, is complemented by the 510(k) approved GloCyte Low and High Level Controls.
“To date, there has not been a way to provide dependable low cell counts,” said John Coughlin, president and CEO of Advanced Instruments. “We use a novel combination of fluorescence, microscopy with digital image analysis principles, highly specific reagents, and an intelligent counting algorithm to provide accurate and precise cell counts. We are very excited as this marks a major achievement in giving laboratories a new way to obtain reliable and timely CSF results.”
Related Links:
Advanced Instruments
The Advanced Instruments, Inc., (Norwood, MA, USA) patented GloCyte Automated Cell Counter System delivers highly accurate and precise total nucleated cell (TNC) and red blood cell (RBC) results using a novel combination of fluorescence technology, highly specific reagents, and an intelligent counting algorithm. It provides accurate cell counts at clinically relevant low levels and reduces valuable time spent counting those more difficult specimens.
Analyses preformed with the GloCyteSystem require only 30 microliters of sample per test. The instrument uses disposable test cartridges ensuring no sample carryover and easy disposal, and it includes built-in quality control.
The GloCyte instrument, which should be available in the USA from September 2016, is complemented by the 510(k) approved GloCyte Low and High Level Controls.
“To date, there has not been a way to provide dependable low cell counts,” said John Coughlin, president and CEO of Advanced Instruments. “We use a novel combination of fluorescence, microscopy with digital image analysis principles, highly specific reagents, and an intelligent counting algorithm to provide accurate and precise cell counts. We are very excited as this marks a major achievement in giving laboratories a new way to obtain reliable and timely CSF results.”
Related Links:
Advanced Instruments
Latest Technology News
- New Diagnostic System Achieves PCR Testing Accuracy
- DNA Biosensor Enables Early Diagnosis of Cervical Cancer
- Self-Heating Microfluidic Devices Can Detect Diseases in Tiny Blood or Fluid Samples
- Breakthrough in Diagnostic Technology Could Make On-The-Spot Testing Widely Accessible
- First of Its Kind Technology Detects Glucose in Human Saliva
- Electrochemical Device Identifies People at Higher Risk for Osteoporosis Using Single Blood Drop
- Novel Noninvasive Test Detects Malaria Infection without Blood Sample
- Portable Optofluidic Sensing Devices Could Simultaneously Perform Variety of Medical Tests
- Point-of-Care Software Solution Helps Manage Disparate POCT Scenarios across Patient Testing Locations
- Electronic Biosensor Detects Biomarkers in Whole Blood Samples without Addition of Reagents
- Breakthrough Test Detects Biological Markers Related to Wider Variety of Cancers
- Rapid POC Sensing Kit to Determine Gut Health from Blood Serum and Stool Samples
- Device Converts Smartphone into Fluorescence Microscope for Just USD 50
- Wi-Fi Enabled Handheld Tube Reader Designed for Easy Portability